| ISIN | CH1244681594 |
|---|---|
| Valor Number | 124468159 |
| Bloomberg Global ID | |
| Fund Name | UBS ETF (CH) - UBS MSCI Switzerland IMI Dividend Screened ETF CHF dis |
| Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Fund Management (Switzerland) AG |
| Representative in Switzerland | |
| Distributor(s) | |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 13.10 CHF | 02.10.2025 |
|---|---|---|
| Previous Price * | 13.03 CHF | 01.10.2025 |
| 52 Week High * | 14.01 CHF | 20.03.2025 |
| 52 Week Low * | 11.95 CHF | 09.04.2025 |
| NAV * | 13.10 CHF | 02.10.2025 |
| Issue Price * | 13.10 CHF | 02.10.2025 |
| Redemption Price * | 13.10 CHF | 02.10.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 42,329,997 | |
| Unit/Share Assets *** | 39,992,210 | |
| Trading Information SIX | ||
| YTD Performance | +6.89% |
31.12.2024 - 02.10.2025
31.12.2024 02.10.2025 |
|---|---|---|
| 1 month | +0.21% |
02.09.2025 - 02.10.2025
02.09.2025 02.10.2025 |
| 3 months | -0.26% |
02.07.2025 - 02.10.2025
02.07.2025 02.10.2025 |
| 6 months | -4.47% |
02.04.2025 - 02.10.2025
02.04.2025 02.10.2025 |
| 1 year | +3.15% |
02.10.2024 - 02.10.2025
02.10.2024 02.10.2025 |
| 2 years | +9.88% |
12.10.2023 - 02.10.2025
12.10.2023 02.10.2025 |
| 3 years | +9.44% |
13.04.2023 - 02.10.2025
13.04.2023 02.10.2025 |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 18.37% | |
|---|---|---|
| Zurich Insurance Group AG | 16.54% | |
| Kuehne + Nagel International AG | 13.00% | |
| Nestle SA | 12.59% | |
| Roche Holding AG | 11.18% | |
| Galenica Ltd | 8.21% | |
| Swiss Re AG | 6.71% | |
| SGS AG | 2.82% | |
| Julius Baer Gruppe AG | 2.25% | |
| Clariant AG Registered Shares | 2.24% | |
| Last data update | 30.09.2025 | |
| TER | 0.20% |
|---|---|
| TER date | 30.06.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.60% |
| Ongoing Charges *** | 0.21% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |